Deforming mirrors converting GMOs into smog

2016 ◽  
Vol 46 (5) ◽  
pp. 620-627
Author(s):  
Roberto Defez

Purpose The debate around the use and study of genetically modified organisms (GMOs) is so complex that frequently people miss that the outcome of some political/social/economic decisions are taken in such a way that the legal/agricultural/medical coherence is lost. The purpose of this text is to underline the contradictions in the European approach to GMOs, when for the past 20 years the European Union (EU) has been using and importing GMOs but rejecting its study or cultivation. Design/methodology/approach The approach follows the distance among public declarations against GMOs from most of the political representatives, followed by decision on our health, nutrition and economic development going exactly in the opposite direction. The arrival of the new genome-edited plants cannot solve all requirements, as in many cases an entire new function should be added and, at present, this will be again a GMO irrespective to the technique used to add a new gene. The delay in taking these decisions are now posing a hazard on the cultural and economic development of the EU. Findings The laws (directives) on GMOs in the EU are far too restrictive and suffer from an over-regulation that prevent any attempt to come to a science-based approach on genetically modified (GM) plants. The basis for the definition and the restrictions is on the technology and not on the final product. However, on the other hand, the GMOs are the only product where the safety analysis is on the final product (which is not the case for organics productions). The paradox is that all restrictions are concentrated on GM plants to be cultivated in Europe, as if the main hazard would be on the environmental impact of local cultivation. Meanwhile, the EU has no concern if the same environmental damage happens abroad and EU is the final user of the technology as 68 different GMOs are imported and used even for human consumption in Europe. Originality/value Fighting against the EU over-regulation would appear to be a position supporting multinational seed companies (none of them based in the EU), described as polluters. The proposed approach is the opposite, asking for a more restrictive regulation to show to the consumers that: most local EU high quality food products are derived from GM-fed animals; GM cotton is potentially far more risky than any GM food; and reducing GM plants cultivated in Europe increases the pesticide sold by chemical companies (mostly based in the EU).

2013 ◽  
Vol 57 (2) ◽  
pp. 5-19 ◽  
Author(s):  
Ewelina Żmijewska ◽  
Dariusz Teper ◽  
Anna Linkiewicz ◽  
Sławomir Sowa

Abstract Maize can be a valuable source of pollen when plants attractive for bees are not available. Honeybees can forage from conventional maize as well as from genetically modified (GM ) maize. The Court of Justice of the European Union (EU ) ruled that pollen in honey must be treated as a food ingredient and therefore falls within the scope of Regulation 1829/2003/EC on GM food and feed and requires authorization. GM pollen unauthorized in the EU cannot be present in honey at any level, and honey must be labelled if it contains more than 0.9% of pollen from authorized GM plants in relation to total pollen content. However, currently available analytical methods allow only for estimation of GM pollen quantity in honey. Therefore, Directive 2001/110/EC related to honey needs to be amended so that pollen can be regarded as a natural constituent of honey. Because the EU is a big honey importer, validated and harmonized detection methods are necessary for the control of GM pollen in honey.


2020 ◽  
Vol 21 (1) ◽  
pp. 11-20
Author(s):  
Anisa ◽  
Chelsilya ◽  
Grace Yohana ◽  
Mucco Eva ◽  
Morry Zefanya ◽  
...  

Current technological advances have been present in all aspects of human life, including technological advances in biotechnology. Biotechnology not only raises hope for science but also raises heated debates among scientists, especially between the European Union and the US. This debate arises because of differences in perspective between the EU and the US. The EU has stringent rules regarding the development efforts of genetically modified organisms (GMOs). At the same time, the US thinks that GMOs are part of agriculture, so there is no need for any special laws to regulate them. Various side effects also come hand in hand with the birth of GMOs. They are ranging from adverse effects on human health, the health of food products, and even environmental damage. The development of GMOs can damage the ecosystem of species that exist in the environment. Still, more complex problems arise due to GMOs like economic problems and monopolies.   Keywords: The  GMOs, The EU, The US.


2020 ◽  
pp. 125-144
Author(s):  
Monika Szkarłat

The European Union can be described as a particular hybrid integration structure that combines features of a state and intergovernmental organisation. Its institutional framework, legal system and division of competences are examples of a supranational organisation or a transnational decision-making system. The decision-making process is an outcome of network interactions between multiple actors, whose relations are non-hierarchically ordered. Genetically modified organisms (GMO) as an example of modern biotechnology application is a highly polarising subject in the EU, as well as globally. Thus, the policy towards GMO is an exemplification of legal and political hybridity of the EU. The analysis of the EU’s legal and political hybridity will be narrowed down to the GM plants case and methodologically organised around the concept of decision-making analysis that is composed of five categories: decision-making situation, actors, decision-making process, decision, implementation of the decision


2007 ◽  
Vol 90 (4) ◽  
pp. 1098-1106 ◽  
Author(s):  
Laetitia Petit ◽  
Galle Pagny ◽  
Fabienne Baraige ◽  
Anne-Ccile Nignol ◽  
David Zhang ◽  
...  

Abstract So far, relatively few genetically modified plants (GMPs) have been planted in the European Union (EU). However, in France, seed batches weakly contaminated by unidentified GM materials have recently been detected among commercial maize seeds (14 seed batches positive out of 447 analyzed). We have developed a 3-step approach to precisely identify the genetic modifications detected in such maize seed batches. First, to isolate GMPs derived from the contaminated seed batches, 10 000 maize seeds of each batch were planted and screened by polymerase chain reaction (PCR) on 100-plant batches, then on 10-plant subbatches, and finally, plant by plant. In a second step, specific identification of the individual GMPs was performed. Finally, to determine the origin of the contamination, each individual GMP was analyzed by simple sequence repeat (SSR) markers. The results showed that all batches were contaminated by few GM seeds, having a GM content <0.1%. Finally, 12 individual GMPs have been isolated from 17 plant pools that were tested positive either for P35-S and/or T-Nos. MON810 and T25 transformation events approved for cultivation in the EU were detected in 7 individual GMPs. The other seed batches were contaminated by genetically modified organisms (GMOs) that are not approved in the EU, including GA21 or the stacking MON810/T25. Presumable identification of T14 was also achieved following sequencing of 1 individual GMP. The data also showed that most of the seed batches were contaminated by several transformation events. Finally, analysis of SSR markers indicated that the contaminations were essentially due to cross-pollination in the seed production process.


2021 ◽  
Author(s):  

The global area of genetically modified (GM) crop production has considerably increased over the past two decades, with GM crops now cultivated in about 28 countries, accounting for over 10% of the world’s arable land. A 'novel food' is any food or substance that has not been used for human consumption to a significant degree within the EU before 15 May 1997. Since then, there has been over 90 novel foods authorisations approved for use by the EU. Novel foods and genetically modified organisms (GMOs) are subject to a large variation in regulatory approaches around the world, for which many countries have specifically developed their own regulatory frameworks to control the placement of such products on their markets.


2016 ◽  
Vol 46 (5) ◽  
pp. 647-658 ◽  
Author(s):  
George Vlontzos ◽  
Marrie Noelle Duquenne

Purpose Since the moment genetically modified organisms (GMOs) and genetically modified (GM) foods first came into the market, there has been a continuous debate between those who are supporters and opponents of them. This paper aims to identify the rationale of acceptance or denial of GM foods into the market. Design/methodology/approach The Health Belief Model (HBM) successfully elucidates the consumer decision-making process for food selection. The questionnaire for this field of research consists of three parts. The first part refers to socioeconomic information, like sex, monthly income and educational level. The second part contains questions derived from the HBM. Interviewees had to use a 1-5 Likert scale for their answers, with 1 representing Total Denial, 3 for Neutral and 5 for Total Agreement. Finally, the third part consists of one question about the willingness to pay for GM foods or not. Findings There are significant differences between Greek consumers and consumers from other European countries – the most important one being their focus on food safety and nutritional issues – with their importance not being reduced by possible pricing discounts. Increase in the market share of GM food can occur only if special focus will be given in the implementation of promotion strategies verifying about the safety of use and increased nutritional value of them, having as a second priority, the implementation of an aggressive pricing policy towards non-GM foods. Originality/value This is an original field research, identifying the rationale of the food selection in the Greek market towards GM foods.


Author(s):  
Andreas Gabriel ◽  
Klaus Menrad

AbstractIn contrast to the increasing use of GM plants in agriculture worldwide, the acceptance of GM food is still low in the European Union. If GM food products were introduced in the EU, the German food industry would be confronted with increased efforts to separate GM and non-GM processing lines and it would have to perform compulsory quality management. This paper analyses the costs of co-existence for producers of frozen pizza and chocolate in Germany. In order to provide an idea of the general magnitude of these costs, an adaptive calculation model was developed, supported by qualitative information from expert interviews for both sectors. The case studies reveal that the possibilities of the companies are quite different in terms of size, infrastructure, and available resources to operate parallel production. Companies which already have sufficient existing facilities to run separated production lines might have the opportunity for specialisation and could manage a possible emerging GM market situation.


2015 ◽  
Vol 6 (4) ◽  
pp. 559-572 ◽  
Author(s):  
Sara Poli

The recently enacted Directive 2015/412 is a long waited piece of legislation. This legislation introduces a new provision in Directive 2001/18, Art. 26 b, which gives Member States the regulatory freedom to decide whether genetically modified organisms (“GMOs”) should be cultivated or not in their territory. One month after the publication of this act in the Official Journal of the EU, the Commission issued a Communication in which it illustrates further legislative changes to the legislation on genetically modified food and feed (“GM food and feed”). On the same day, the Commission has tabled a proposal for a Regulation, amending Regulation 1829/2003 (the “proposed reform of GM food and feed”) that envisages the possibility for the Member States to restrict or prohibit the use of GM food and feed on their territory. The proposed act is described as a complement to Directive 2015/412 and is inspired by the same principles.


2002 ◽  
Vol 3 (5) ◽  
Author(s):  
Patrycja Dabrowska

The first directives regulating the use and trade of genetically modified organisms (GMOs) were adopted at the Community level in 1990. These acts formed a core of the Community gene technology legal regime and harmonised the authorisation procedures prior to both contained use and deliberate release of genetically modified organisms. Accordingly, no GMO may be placed on the European Union market without obtaining a written consent for it and only after an appropriate environmental risk assessment has been carried out. Under the old Deliberate Release Directive 90/220, 18 GM products were allowed to be placed on the Community market following either the Commission decisions or Member States consent and over 1000 were notified to the Member States authorities for experimental purposes.


2020 ◽  
pp. 107554702098137
Author(s):  
Leticia Bode ◽  
Emily K. Vraga ◽  
Melissa Tully

We experimentally test whether expert organizations on social media can correct misperceptions of the scientific consensus on the safety of genetically modified (GM) food for human consumption, as well as what role social media cues, in the form of “likes,” play in that process. We find expert organizations highlighting scientific consensus on GM food safety reduces consensus misperceptions among the public, leading to lower GM misperceptions and boosting related consumption behaviors in line with the gateway belief model. Expert organizations’ credibility may increase as a result of correction, but popularity cues do not seem to affect misperceptions or credibility.


Sign in / Sign up

Export Citation Format

Share Document